Neglected outcomes of cerebrovascular disorders in neuromuscular diseases

IF 3.9 2区 医学 Q1 CLINICAL NEUROLOGY European Journal of Neurology Pub Date : 2024-11-27 DOI:10.1111/ene.16569
Benedikt Schoser
{"title":"Neglected outcomes of cerebrovascular disorders in neuromuscular diseases","authors":"Benedikt Schoser","doi":"10.1111/ene.16569","DOIUrl":null,"url":null,"abstract":"<p>Stroke and multisystemic features are easily overlooked in neuromuscular disorders (NMDs). The scientific literature is limited to this topic, and long-term outcomes are rarely reported. In this issue, Al-Salahat and colleagues report on cerebrovascular diseases (CVDs) outcomes in patients with muscular dystrophies (MD). A 10-year screening in their nationwide readmission database identified hospitalizations for CVDs, including ischemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, and other unspecified CVDs.</p><p>They found in 6,129,132 CVD hospitalizations, that 0.03% (2098) were MD patients. Ischemic stroke was the most common type, followed by intracerebral hemorrhage. MD patients had 41% lower odds of routine discharge, 9% greater costs, 30% lower odds of 90-day all-cause readmissions, and a higher in-patient mortality [<span>1</span>]. These results point clearly towards a higher risk of scarce outcomes of CVD in MD patients. This emphasizes a high need for boosted access to amended post-discharge care, like stroke rehabilitation for people living with MD.</p><p>Therefore, the authors presented an essential work for the overall health of neuromuscular patients. To widen the scope of this report, considering stroke sequelae and outcomes in Duchenne muscular dystrophy, the most frequent x-linked MD in young adults, one report, covering a total observation period of 400 patient-years, identified four DMD with juvenile arterial ischemic strokes. Systemic thrombolysis in two patients resulted in a regression of stroke symptoms, but one patient died of septic pneumonia and cardiac failure 24 days after thrombolysis. Both other patients persisted with severe infarction-related symptoms, with an early death in one of them. DMD-associated cardiomyopathy without evidence of atrial fibrillation was the only risk factor for ischemic stroke in all patients [<span>2</span>].</p><p>Looking at metabolic lysosomal neuromuscular disorders, Fabry disease has an esteemed birth prevalence ranging from 1 in 476,000 to 1 in 117,000. However, for stroke neurologists, recognizing the X-linked lysosomal storage disorder of glycosphingolipid metabolism is still challenging. According to FD registry data, up to 15% of patients may experience a stroke [<span>3</span>]. Cerebrovascular manifestations of FD may include thrombosis, transient ischemic attacks, basilar artery ischemia and aneurysm, seizures, hemiplegia, hemianesthesia, aphasia, labyrinthine disorders, or cerebral hemorrhage. Individuals living with FD may have increased basilar artery mean diameter and linear length compared with controls. White matter lesions are frequently found on brain MRIs of FD; age and prior stroke independently predicted the burden of white matter hyperintensities [<span>3</span>]. Similarly, in another lysosomal storage disorder, Pompe disease, stroke-related sequelae of megadolichobasliaris, stroke, and subarachnoidal hemorrhage can occur [<span>4-6</span>].</p><p>Finally, stroke-like episodes as paroxysmal neurological sequelae may be part of specific mitochondrial diseases. It is essential to differentiate stroke-like episodes from cerebral infarction or intracerebral hemorrhage, mainly due to the variety in management. Focal-onset seizures, encephalopathy, and visual disturbances are prominent findings associated with stroke-like episodes, with a preference for the posterior cerebral cortex resulting in progressive brain atrophy and dementia. The most common cause of stroke-like episodes is the m.3243A &gt; G variant in MT-TL1 gene, resulting in mitochondrial myopathy, encephalopathy, lactacidosis, and stroke (MELAS). Seizure management is warranted [<span>7, 8</span>].</p><p>In conclusion, stroke and other cerebrovascular disorders in younger patients should alert stroke neurologists to search and screen for a genetic (neuromuscular) background. For improvement of the overall stroke prognosis in NMDs, personalized care needs to be better defined.</p><p><b>Benedikt Schoser:</b> Conceptualization; writing – review and editing; data curation; project administration; validation; writing – original draft; investigation; formal analysis; supervision; resources.</p><p>The author reports no conflict of interest.</p>","PeriodicalId":11954,"journal":{"name":"European Journal of Neurology","volume":"32 1","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11625925/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Neurology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ene.16569","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Stroke and multisystemic features are easily overlooked in neuromuscular disorders (NMDs). The scientific literature is limited to this topic, and long-term outcomes are rarely reported. In this issue, Al-Salahat and colleagues report on cerebrovascular diseases (CVDs) outcomes in patients with muscular dystrophies (MD). A 10-year screening in their nationwide readmission database identified hospitalizations for CVDs, including ischemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, and other unspecified CVDs.

They found in 6,129,132 CVD hospitalizations, that 0.03% (2098) were MD patients. Ischemic stroke was the most common type, followed by intracerebral hemorrhage. MD patients had 41% lower odds of routine discharge, 9% greater costs, 30% lower odds of 90-day all-cause readmissions, and a higher in-patient mortality [1]. These results point clearly towards a higher risk of scarce outcomes of CVD in MD patients. This emphasizes a high need for boosted access to amended post-discharge care, like stroke rehabilitation for people living with MD.

Therefore, the authors presented an essential work for the overall health of neuromuscular patients. To widen the scope of this report, considering stroke sequelae and outcomes in Duchenne muscular dystrophy, the most frequent x-linked MD in young adults, one report, covering a total observation period of 400 patient-years, identified four DMD with juvenile arterial ischemic strokes. Systemic thrombolysis in two patients resulted in a regression of stroke symptoms, but one patient died of septic pneumonia and cardiac failure 24 days after thrombolysis. Both other patients persisted with severe infarction-related symptoms, with an early death in one of them. DMD-associated cardiomyopathy without evidence of atrial fibrillation was the only risk factor for ischemic stroke in all patients [2].

Looking at metabolic lysosomal neuromuscular disorders, Fabry disease has an esteemed birth prevalence ranging from 1 in 476,000 to 1 in 117,000. However, for stroke neurologists, recognizing the X-linked lysosomal storage disorder of glycosphingolipid metabolism is still challenging. According to FD registry data, up to 15% of patients may experience a stroke [3]. Cerebrovascular manifestations of FD may include thrombosis, transient ischemic attacks, basilar artery ischemia and aneurysm, seizures, hemiplegia, hemianesthesia, aphasia, labyrinthine disorders, or cerebral hemorrhage. Individuals living with FD may have increased basilar artery mean diameter and linear length compared with controls. White matter lesions are frequently found on brain MRIs of FD; age and prior stroke independently predicted the burden of white matter hyperintensities [3]. Similarly, in another lysosomal storage disorder, Pompe disease, stroke-related sequelae of megadolichobasliaris, stroke, and subarachnoidal hemorrhage can occur [4-6].

Finally, stroke-like episodes as paroxysmal neurological sequelae may be part of specific mitochondrial diseases. It is essential to differentiate stroke-like episodes from cerebral infarction or intracerebral hemorrhage, mainly due to the variety in management. Focal-onset seizures, encephalopathy, and visual disturbances are prominent findings associated with stroke-like episodes, with a preference for the posterior cerebral cortex resulting in progressive brain atrophy and dementia. The most common cause of stroke-like episodes is the m.3243A > G variant in MT-TL1 gene, resulting in mitochondrial myopathy, encephalopathy, lactacidosis, and stroke (MELAS). Seizure management is warranted [7, 8].

In conclusion, stroke and other cerebrovascular disorders in younger patients should alert stroke neurologists to search and screen for a genetic (neuromuscular) background. For improvement of the overall stroke prognosis in NMDs, personalized care needs to be better defined.

Benedikt Schoser: Conceptualization; writing – review and editing; data curation; project administration; validation; writing – original draft; investigation; formal analysis; supervision; resources.

The author reports no conflict of interest.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
神经肌肉疾病中被忽视的脑血管疾病后果。
中风和多系统特征在神经肌肉疾病(nmd)中很容易被忽视。科学文献仅限于这一主题,长期结果很少报道。在本期杂志中,Al-Salahat及其同事报道了肌营养不良症(MD)患者的脑血管疾病(cvd)结局。在他们的全国再入院数据库中进行了10年的筛查,确定了心血管疾病的住院情况,包括缺血性中风、脑出血、蛛网膜下腔出血和其他未指明的心血管疾病。他们发现,在6129132例心血管疾病住院患者中,0.03%(2098例)是MD患者。缺血性中风是最常见的类型,其次是脑出血。MD患者常规出院的几率低41%,费用高9%,90天全因再入院的几率低30%,住院死亡率更高。这些结果清楚地指出,心血管疾病的稀缺结局在MD患者中的风险更高。这强调了对改进的出院后护理的高度需求,如对医学患者的中风康复。因此,作者提出了一项针对神经肌肉患者整体健康的重要工作。为了扩大本报告的范围,考虑到年轻成人中最常见的x连锁MD杜氏肌营养不良的卒中后遗症和结局,一份报告涵盖了400患者年的总观察期,确定了4例DMD伴青少年动脉缺血性卒中。2例患者全身溶栓导致卒中症状消退,但1例患者在溶栓后24天死于感染性肺炎和心力衰竭。其他两名患者持续出现严重的梗死相关症状,其中一人早期死亡。无房颤证据的dmd相关心肌病是所有患者缺血性卒中的唯一危险因素。看看代谢性溶酶体神经肌肉疾病,法布里病的出生患病率从47.6万分之一到11.7万分之一不等。然而,对于中风神经科医生来说,认识到鞘糖脂代谢的x连锁溶酶体储存障碍仍然是一个挑战。根据FD注册数据,高达15%的患者可能会经历脑卒中。FD的脑血管表现包括血栓形成、短暂性脑缺血发作、基底动脉缺血及动脉瘤、癫痫发作、偏瘫、半麻醉、失语、迷路障碍或脑出血。与对照组相比,患有FD的个体基底动脉的平均直径和线性长度可能增加。FD的脑mri多见白质病变;年龄和既往中风独立预测白质高强度[3]的负担。同样,在另一种溶酶体贮积疾病Pompe病中,也可能发生脑卒中相关的大宽宽性脊柱炎后遗症、中风和蛛网膜下腔出血[4-6]。最后,中风样发作作为阵发性神经系统后遗症可能是特定线粒体疾病的一部分。区分脑卒中样发作与脑梗死或脑出血是必要的,主要是由于治疗方法的多样性。局灶性癫痫发作、脑病和视觉障碍是与卒中样发作相关的突出表现,大脑后皮层优先发生,导致进行性脑萎缩和痴呆。中风样发作最常见的原因是MT-TL1基因的m.3243A >; G变异,导致线粒体肌病、脑病、乳酸中毒和中风(MELAS)。癫痫发作管理是必要的[7,8]。总之,中风和其他脑血管疾病的年轻患者应该提醒中风神经科医生寻找和筛选遗传(神经肌肉)背景。为了改善nmd的整体卒中预后,需要更好地定义个性化护理。本尼迪克特·肖泽:概念化;写作——审阅和编辑;数据管理;项目管理;验证;写作——原稿;调查;正式的分析;监督;资源。作者报告无利益冲突。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Journal of Neurology
European Journal of Neurology 医学-临床神经学
CiteScore
9.70
自引率
2.00%
发文量
418
审稿时长
1 months
期刊介绍: The European Journal of Neurology is the official journal of the European Academy of Neurology and covers all areas of clinical and basic research in neurology, including pre-clinical research of immediate translational value for new potential treatments. Emphasis is placed on major diseases of large clinical and socio-economic importance (dementia, stroke, epilepsy, headache, multiple sclerosis, movement disorders, and infectious diseases).
期刊最新文献
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab—A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS) How Much Difference Does Depression Make to the Outcome of Neuropsychological Assessments of Patients With Epilepsy? Neurofilament Light Chain Concentration in the Prediction of Treatment Response in Multiple Sclerosis Long-Term Survival and Life Expectancy After Spinal Cord Injury in Salzburg, Austria: A Retrospective Population-Based Study The PERISCOPE Cohort: A Retrospective Study of Clinicopathological and TRAF7 Genetic Findings in Intraneural Perineurioma.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1